Nurix Therapeutics, Inc. (NRIX)
USD 20.24
(-4.44%)
USD 20.24
(-4.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 76.98 Million | 38.62 Million | 29.75 Million | 17.82 Million | 31.11 Million | 37.44 Million |
| Cost of Revenue | 189.14 Million | 10.8 Million | 6.08 Million | 66.49 Million | 45.02 Million | 40.51 Million |
| Gross Profit | -112.16 Million | 27.81 Million | 23.66 Million | -48.67 Million | -13.91 Million | -3.06 Million |
| Operating Expenses | 232.05 Million | 222.49 Million | 147.63 Million | 82.8 Million | 53.35 Million | 47.18 Million |
| Selling, General and Administrative Expenses | 42.9 Million | 37.99 Million | 31.2 Million | 16.3 Million | 8.32 Million | 6.67 Million |
| Research and Development Expenses | 189.14 Million | 184.49 Million | 116.43 Million | 66.49 Million | 45.02 Million | 40.51 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 232.05 Million | 222.49 Million | 147.63 Million | 82.8 Million | 53.35 Million | 47.18 Million |
| Operating Income | -155.06 Million | -183.86 Million | -117.88 Million | -64.98 Million | -22.23 Million | -9.73 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -14.31 Million | 131 Thousand | -20.53 Million | 239 Thousand | 507 Thousand |
| Earnings before Tax | -143.94 Million | -180.36 Million | -117.06 Million | -63.77 Million | -21.46 Million | -8.92 Million |
| Net Income | -143.94 Million | -166.04 Million | -117.19 Million | -43.24 Million | -21.69 Million | -9.42 Million |
| Earnings Per Share Basic | -2.65 | -3.42 | -2.73 | -2.76 | -0.56 | -0.59 |
| Earnings Per Share Diluted | -2.65 | -3.42 | -2.73 | -2.76 | -0.56 | -0.59 |
| Weighted Average Shares Outstanding | 54.33 Million | 48.6 Million | 42.89 Million | 15.67 Million | 38.84 Million | 16.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.33 Million | 48.6 Million | 42.89 Million | 15.67 Million | 38.84 Million | 16.1 Million |
| Gross Margin | -1.46 | 0.72 | 0.80 | -2.73 | -0.45 | -0.08 |
| EBIT Margin | -1.84 | -4.76 | -3.96 | -3.65 | -0.64 | -0.18 |
| Profit Margin | -1.87 | -4.30 | -3.94 | -2.43 | -0.70 | -0.25 |
| EBITDA | -141.4 Million | -173.05 Million | -111.8 Million | -62.8 Million | -19.88 Million | -6.75 Million |
| Earnings Before Tax Margin | -2.01 | -4.76 | -3.96 | -3.65 | -0.71 | -0.26 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 12.58 Million | 12.09 Million | 16.58 Million | 76.98 Million | 15.15 Million | 18.46 Million |
| Cost of Revenue | 4.14 Million | 4.09 Million | 3.88 Million | 13.65 Million | 3.75 Million | 3.38 Million |
| Gross Profit | 8.44 Million | 8 Million | 12.69 Million | 63.33 Million | 11.4 Million | 15.08 Million |
| Operating Expenses | 67.19 Million | 56.54 Million | 57.91 Million | 218.39 Million | 56.73 Million | 58.47 Million |
| Selling, General and Administrative Expenses | 11.71 Million | 9.94 Million | 9.95 Million | - | 8.95 Million | 10.62 Million |
| Research and Development Expenses | 55.48 Million | 46.59 Million | 47.96 Million | - | 47.77 Million | 47.85 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 67.19 Million | 60.63 Million | 61.8 Million | 232.05 Million | 60.49 Million | 58.47 Million |
| Operating Income | -54.61 Million | -48.54 Million | -45.21 Million | -155.06 Million | -45.33 Million | -40.01 Million |
| Interest Expense | - | - | - | - | 7.88 Million | - |
| Income Tax Expense | 82 Thousand | 90 Thousand | 90 Thousand | 13.48 Million | 7.88 Million | 3.42 Million |
| Earnings before Tax | -48.87 Million | -44.45 Million | -41.42 Million | -143.94 Million | -41.95 Million | -36.98 Million |
| Net Income | -48.95 Million | -44.54 Million | -41.51 Million | -143.94 Million | -41.95 Million | -36.98 Million |
| Earnings Per Share Basic | -0.67 | -0.71 | -0.76 | - | -0.77 | -0.68 |
| Earnings Per Share Diluted | -0.67 | -0.71 | -0.76 | - | -0.77 | -0.68 |
| Weighted Average Shares Outstanding | 72.77 Million | 62.37 Million | 54.9 Million | 54.33 Million | 54.67 Million | 54.39 Million |
| Weighted Average Shares Outstanding (Diluted) | 72.77 Million | 62.37 Million | 54.9 Million | 54.33 Million | 54.67 Million | 54.39 Million |
| Gross Margin | 0.67 | 0.66 | 0.77 | 0.82 | 0.75 | 0.82 |
| EBIT Margin | -4.34 | -3.68 | -2.49 | - | -2.74 | -1.98 |
| Profit Margin | -3.89 | -3.68 | -2.50 | -1.87 | -2.77 | -2.00 |
| EBITDA | -54.61 Million | -44.44 Million | -41.33 Million | - | -41.57 Million | -36.62 Million |
| Earnings Before Tax Margin | -4.34 | -4.01 | -2.73 | -2.01 | -2.99 | -2.17 |
420770
MMM
603699
WLKP
YY
0ILW